购物车
- 全部删除
- 您的购物车当前为空
TfR-1-IN-1(compound C4)是转铁蛋白受体1(TfR-1)抑制剂,显示出抗癌特性。该化合物显著提升了细胞内铁(II)的水平,从而促进铁死亡(ferroptosis)。在卵巢癌(A2780cis)、乳腺癌(MDA-MB 231)和白血病(HL-60)细胞系中,TfR-1-IN-1有效降低了代谢活性,其IC50值分别为0.51、0.46和0.48 μM。
TfR-1-IN-1(compound C4)是转铁蛋白受体1(TfR-1)抑制剂,显示出抗癌特性。该化合物显著提升了细胞内铁(II)的水平,从而促进铁死亡(ferroptosis)。在卵巢癌(A2780cis)、乳腺癌(MDA-MB 231)和白血病(HL-60)细胞系中,TfR-1-IN-1有效降低了代谢活性,其IC50值分别为0.51、0.46和0.48 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | TfR-1-IN-1 (compound C4), an inhibitor of transferrin receptor 1 (TfR-1), exhibits potent anticancer properties. This compound notably elevates intracellular iron (II) levels, which serve as a catalyst for ferroptosis induction. Additionally, TfR-1-IN-1 effectively diminishes the metabolic activity in various cancer cell lines, including ovarian cancer (A2780cis), breast cancer (MDA-MB 231), and leukemia (HL-60), with respective IC50 values of 0.51, 0.46, and 0.48 µM. |
分子量 | 441.62 |
分子式 | C20H12ClF2FeN2O2 |
CAS No. | 1643444-62-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容